1. Unveiling Cas12j Trans‐Cleavage Activity for CRISPR Diagnostics: Application to miRNA Detection in Lung Cancer Diagnosis
   Ju‐Eun Kang et al, 2024, Advanced Science CrossRef
2. MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
   Javaid Ahmad Wani et al, 2022, Diagnostics CrossRef
3. A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer
   Chiara Gargiuli et al, 2022, Frontiers in Oncology CrossRef
4. Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression
   Janson Tse et al, 2022, Cancers CrossRef
5. Medical Relevance, State-of-the-Art and Perspectives of “Sweet Metacode” in Liquid Biopsy Approaches
   Andrea Pinkeova et al, 2024, Diagnostics CrossRef
6. miRNAs in Cancer (Review of Literature)
   Beata Smolarz et al, 2022, International Journal of Molecular Sciences CrossRef
7. The clinical diagnostic value of plasma miR-592 and miR-217-3p levels in retinoblastoma
   Luo Yan et al, 2022, Journal of Medical Biochemistry CrossRef
8. Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer
   Yi Lin et al, 2022, Pathology - Research and Practice CrossRef
9. Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy
   Ziyu Jiang et al, 2022, Journal of Nanomaterials CrossRef
10. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
    Cameron Brown et al, 2022, Cardio-Oncology CrossRef
11. Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients
    Justyna Raczkowska et al, 2023, Frontiers in Oncology CrossRef
12. Increased oxygen stimulation promotes chemoresistance and phenotype shifting through PLCB1 in gliomas
    Kang Ma et al, 2024, Drug Resistance Updates CrossRef
13. Circulating miR-1-3p, miR-96-5p, miR-148a-3p, and miR-375-3p support differentiation between prostate cancer and benign prostate lesions
    Rafał Osiecki et al, 2024, Clinical Genitourinary Cancer CrossRef
14. miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells
    Wei-An Chang et al, 2021, Cancers CrossRef
15. Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma
    Zhao Yang et al, 2024, Chemical Engineering Journal CrossRef
16. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review)
    Xindi Liang et al, 2022, Oncology Reports CrossRef